A thymic peptide studied for immune regulation, T-cell maturation, and balanced immune responses.
Thymosin Alpha-1 Protocol
Immune · Inflammation, Longevity, Recovery
Protocol Details
Dose
15 units (0.75mg)
Frequency
3 days / week
Administration
Subcutaneous
Timing
AM or PM
Vial Size
10mg
Reconstitution
2mL Bacteriostatic Water
Cycle Length
3 months on, 1 month off
Vials / Month
1
Vials / Cycle
3
Benefits
- Studied for enhancing T-cell function and immune surveillance
- Explored for balancing Th1/Th2 immune responses
- May support immune resilience against infections
- Researched as adjunct therapy in hepatitis B and C
- Studied for reducing immune-related inflammation and autoimmunity
How it Works
Thymosin Alpha-1 is a 28-amino-acid peptide naturally produced by the thymus gland.
It promotes maturation and differentiation of T-cells critical for adaptive immunity.
The peptide activates dendritic cells, enhancing antigen presentation and immune recognition.
It modulates the balance between pro- and anti-inflammatory cytokines for immune homeostasis.
This protocol is an educational reference only, not medical advice. Consult a licensed clinician before beginning any peptide protocol.
Questions about Thymosin Alpha-1?
Powered by LoopAI